Genetic evaluations and testing rates for hereditary breast and ovarian cancer syndrome in a community oncology setting.

被引：0
|
作者：
Bunnell, Ann
Principe, Kate
Patel, Gayle
Nichols, Trisha
Mokhtary, Sara
Sandbach, John F.
Torres, Vanessa
机构：
[1] Texas Oncol, Irving, TX USA
[2] Texas Oncol, Houston, TX USA
[3] Texas Oncol, Austin, TX USA
[4] Texas Oncol, Plano, TX USA
[5] Texas Oncol, San Antonio, TX USA
[6] Texas Oncol Cent Austin, Austin, TX USA
[7] Texas Oncol, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22533
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Genetic cancer screening: process of identification of appropriate patients for testing in a community oncology setting.
    Peerboom, J
    [J]. ONCOLOGY NURSING FORUM, 2006, 33 (02) : 449 - 449
  • [2] The uptake of presymptomatic genetic testing for hereditary breast and/or ovarian cancer syndrome
    Barbara, Babuder
    Simona, Hotujec
    Ana, Blatni
    Ksenija, Strojnik
    Marta, Banjac
    Srdjan, Novakovic
    Mateja, Krajc
    [J]. ONKOLOGIJA, 2021, 25 (02) : 16 - 23
  • [3] Rates of appropriate genetic testing referral for breast cancer patients treated in multidisciplinary cancer care setting.
    Gomez, Caitlin Laurel
    Dawson, Nicole Ann
    Dvorak, Robyn Lynn
    Foster, Nova
    Hoyt, Anne
    Hurvitz, Sara A.
    Kusske, Amy
    Tseng, Charles Y.
    McCloskey, Susan Ann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [4] Lessons learned from clinical genetic testing for hereditary breast and ovarian cancer (HBOC) syndromes in community and academic oncology centers
    Connors, Laurie M.
    Yi, W. Sam
    Voian, Nicoleta
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] The impact of social determinants of health (SDOH) on use of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting.
    Reid, Robert Lawrence
    Dye, Joseph
    Leong, Traci
    Kunz, Barbara
    Danso, Michael A.
    Espirito, Janet L.
    Tedesco, Karen L.
    Goudar, Ranjit
    Lewis, Tifany
    Clark, Becky
    Adger, Rachael
    Kocemba, Leanne
    Mendenhall, Molly
    Robert, Nicholas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Genetic testing for hereditary breast and ovarian cancer: Responsibility and choice
    d'Agincourt-Canning, L
    [J]. QUALITATIVE HEALTH RESEARCH, 2006, 16 (01) : 97 - 118
  • [7] Genetic testing for patients at risk of hereditary breast and ovarian cancer
    DeTroye, Alisha
    Gabbett, Kayla
    Yi, Cheryl
    Judice, Melanie
    Luu, Victor
    Nelson, Brittany
    Gregory, Tanya
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (10): : 48 - 52
  • [8] The changing landscape of genetic testing for hereditary breast and ovarian cancer
    Bellcross, Cecelia A.
    [J]. CURRENT PROBLEMS IN CANCER, 2014, 38 (06) : 209 - 215
  • [9] Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations
    Wood, Marie E.
    Garber, Judy E.
    Isaacs, Claudine
    Masood, Shahla
    Bedrosian, Isabelle
    Tung, Nadine
    Chun, Jennifer
    Schnabel, Freya R.
    Arun, Banu K.
    [J]. BREAST JOURNAL, 2019, 25 (04): : 575 - 577
  • [10] Age disparity in Oncotype DX testing in a community oncology setting.
    Khajuria, Suheir
    Adams, Ashley
    Schreiber, Andrew Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
12345